AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE500.80-0.5 (-0.1 %)
PREV CLOSE ( ) 501.30
OPEN PRICE ( ) 494.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9785
TODAY'S LOW / HIGH ( )494.85 504.30
52 WK LOW / HIGH ( )408.95 645
NSE500.20-0.55 (-0.11 %)
PREV CLOSE( ) 500.75
OPEN PRICE ( ) 499.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 500.20 (300)
VOLUME 68793
TODAY'S LOW / HIGH( ) 498.55 504.30
52 WK LOW / HIGH ( )409 645.75

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.